Orano Med is at the forefront of research in nuclear medicine and is developing new therapies against cancer. Based on its unique expertise in the production of lead-212 (Pb-212) and radiolabeling technologies, Orano Med is developing innovative radioligand therapies which consist of selectively destroying cancer cells while limiting the impact on surrounding healthy cells.
With a solid portfolio of molecules in development capable of targeting various forms of cancer, and a reliable supply chain for Pb-212, Orano Med aims to become a leader in targeted alpha therapies, in particular for patients with currently unmet medical needs.
The Program & Project Management Leader (PPML) is a senior drug development leader with exceptional strategic and collaborative skills. This individual will directly lead one or more development program(s). In addition, this newly created role at Orano Med will also establish the key processes and tools in order to establish a fit for purpose function in order to support the rapid expansion of our pipeline of future cancer medicines based on our leading Pb212-based alpha therapy platform.
Primary Responsibilities:
All candidates must meet the following minimum requirements in order to be considered for this opportunity:
***Targeting remote workers on the East Coast.